KALA BIO, Inc. (KALA) Earnings History
Annual and quarterly earnings data from 2013 to 2024
Loading earnings history...
KALA EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
KALA Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | 34.2% | -2090.3% | -1151.6% |
| 2021 | 63.5% | -973.6% | -1268.7% |
| 2020 | 50.1% | -1512.6% | -1639.8% |
Download Data
Export KALA earnings history in CSV or JSON format
Free sign-in required to download data
KALA BIO, Inc. (KALA) Earnings Overview
As of May 8, 2026, KALA BIO, Inc. (KALA) reported trailing twelve-month net income of -$36M, reflecting +59.8% year-over-year growth. The company earned $-5.09 per diluted share over the past four quarters.
Looking at the long-term picture, KALA's historical earnings data spans multiple years. The company achieved its highest annual net income of -$11M in fiscal 2013.
KALA BIO, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including OCUL (-$290M net income, -513.2% margin), LNTH ($279M net income, 15.2% margin), HROW (-$5M net income, -1.9% margin), KALA has comparable earnings metrics. Compare KALA vs OCUL →
KALA Earnings vs Peers
Earnings metrics vs comparable public companies
KALA Historical Earnings Data (2013–2024)
12 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$39M | +8.7% | -$41M | $-6.98 | - | - |
| 2023 | -$42M | +5.9% | -$39M | $-17.35 | - | - |
| 2022 | -$45M | +68.6% | -$81M | $-29.48 | -1151.6% | -2090.3% |
| 2021 | -$143M | -36.7% | -$109M | $-109.35 | -1268.7% | -973.6% |
| 2020 | -$104M | -10.6% | -$96M | $-99.59 | -1639.8% | -1512.6% |
| 2019 | -$94M | -41.4% | -$88M | $-149.06 | -1553.3% | -1452.5% |
| 2018 | -$67M | -58.1% | -$65M | $-124.73 | - | - |
| 2017 | -$42M | -27.3% | -$40M | $-99.20 | - | - |
| 2016 | -$33M | -98.8% | -$33M | $-95.95 | - | - |
| 2015 | -$17M | +13.8% | -$16M | $-48.26 | -37071.1% | -35435.6% |
See KALA's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs KALA Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare KALA vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonKALA — Frequently Asked Questions
Quick answers to the most common questions about buying KALA stock.
Is KALA growing earnings?
KALA EPS is $-5.09, with earnings growth accelerating to +59.8%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-36M.
What are KALA's profit margins?
KALA BIO, Inc. net margin is N/A, with operating margin at N/A. Below-average margins reflect competitive or cost pressures.
How consistent are KALA's earnings?
KALA earnings data spans 2013-2024. The accelerating earnings trend is +59.8% YoY. Historical data enables comparison across business cycles.